Bayesian calibration of a physiologically based pharmacokinetic/ pharmacodynamic model of carbaryl cholinesterase inhibition

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 71, Issue 20, 2008, Pages 1363-1381

  Nong, Andy ^a   Tan, Yu Mei ^a   Krolski, Michael E ^b   Wang, Jiansuo ^a   Lunchick, Curt ^c   Conolly, Rory B ^a   Clewell III, Harvey J ^a  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b BAYER CORPORATION   (United States)

^c BAYER CROPSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBARYL CHOLINESTERASE INHIBITOR; CHOLINESTERASE INHIBITOR; INSECTICIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAYES THEOREM; CALIBRATION; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; INHIBITION KINETICS; ISOTOPE TRACING; MALE; MATHEMATICAL MODEL; MONTE CARLO METHOD; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PROBABILITY; RAT;

ADMINISTRATION, ORAL; ANIMALS; BAYES THEOREM; BRAIN; CARBARYL; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; LIVER; MARKOV CHAINS; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; RATS; TISSUE DISTRIBUTION;

RATTUS;

EID: 49649113402     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390802271608     Document Type: Article

References (50)

1. Arms, A. D., and Travis, C. C. 1988. Reference physiological parameters in pharmacokinetic modeling. EPA/600/6-88/004. Washington, DC: U.S. Environmental Protection Agency.
2. Banerjee, J., Ghosh, P., Mitra, S., Ghosh, N., and Bhattacharya, S. 1991. Inhibition of human fetal brain acetylcholinesterase: marker effect of neurotoxicity. J. Toxicol. Environ. Health 33:283-290.
3. Bernillon, P., and Bois, F. Y. 2000. Statistical issues in toxicokinetic modeling: A Bayesian perspective. Environ. Health Perspect. 108:883-893.
4. Bois, F. 2000. Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics. Environ. Health. Perspect. 108 (Suppl. 2):307-316.
5. Bois, F. Y., Jackson, E. T., Pekari, K., and Smith, M. T. 1996. Population toxicokinetics of benzene. Environ. Health. Perspect. 104:1405-1411.
6. Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., and Beliles, R. P. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13:407-484.
7. Cambon, C., Fernandez, Y., Falzon, M., and Mitjavila, S. 1981. Variations of the digestive absorption kinetics of carbaryl with the nature of the vehicle. Toxicology 22:45-51.
8. Cambon, C., Declume, C., and Derache, R. 1980. Fetal and maternal rat brain acetylcholinesterase: Isoenzymes changes following insecticidal carbamate derivatives poisoning. Arch. Toxicol. 45:257-262.
9. Carlin, B. P., and Louis, T. A. 2000. Bayes and empirical Bayes methods for data analysis, 2nd ed. Boca Raton, FL: Chapman & Hall/CRC.
10. Carpenter, C. P., Weil, C. W., Palm, P. E., Woodside, M. W., Nair, J. H. III, and Smyth, H. F., Jr. 1961. Mammalian toxicity of 1-naphthyl-N-methylcarbamate (Sevin insecticide). J. Agric. Food Chem. 9:30-39.
11. Dawson, R. 1994. Rate constants of carbamylation and decarbamylation of acetylcholinesterase for physostigmine and carbaryl in the presence of an oxime. Neurochem. Int. 24:173-182.
12. 14C] carbaryl in rats and mice. Autoradiographic study. Toxicology 8:95-105.
13. Fernandez, Y., Falzon, M., Cambon-Gros, C., and Mitjavila, S. 1982. Carbaryl tricompartmental toxicokinetics and anticholinesterase activity. Toxicol. Lett. 13:253-258.
14. Fillmore, C., and Lessenger, J. 1993. A cholinesterase testing program for pesticide applicators. J. Occup. Med. 35:61-70.
15. Gearhart, J., Jepson, G., Clewell, H., Andersen, M., and Conolly, R. 1990. A physiologically-based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by disopropylfluorophosphate. Toxicol. Appl. Pharmacol. 106:295-310.
16. Gearhart, J., Jepson, G., Clewell, H., Andersen, M., and Conolly, R. 1994. Physiologically-based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by organophosphate esters. Environ. Health Perspect. 102:51-60.
17. Hack, C. E. 2006. Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models. Toxicology. 221:241-248.
18. Houston, J. B., Upshall, D. G., and Bridges, J. W. 1975. Pharmacokinetics and metabolism of two carbamate insecticides, carbaryl and landrin, in the rat. Xenobiotica 5:637-648.
19. International Programme on Chemical Safety. 1994. Carbaryl. EHC 153. Geneva: World Health Organization.
20. Jonsson, F., Bois, F., and Johanson, G. 2001. Physiologically based pharmacokinetic modeling of inhalation exposure of humans to dichloromethane during moderate to heavy exercise. Toxicol. Sci. 59:209-218.
21. Knaak, J. B., Tallant, M. J., Bartley, W. J., and Sullivan, L. J. 1965. The metabolism of carbaryl in the rat, guinea pig, and man. J. Agric. Food Chem. 13:537-543.
22. Knight, E. V., Alvares, A. P., and Chin, B. H. 1987. Effects of phenobarbital pretreatment on the in vivo metabolism of carbaryl in rats. Bull. Environ. Contam. Toxicol. 39:815-821.
23. Lechner, D. W., and Abdel-Rahman, M. S. 1985. Alterations in rat liver microsomal enzymes following exposure to carbaryl and malathion in combination. Arch. Environ. Contam. Toxicol. 14:451-457.
24. Lockridge, O., and Masson, P. 2000. Pesticides and susceptible populations: People with butyrylcholinesterase genetic variants may be at risk. Neurotoxicology. 21:113-126.
25. Main, A. R., Tarkan, E., Aull, J. L., and Soucie, W. G. 1972. Purification of horse serum cholinesterase by preparative polyacrylamide gel electrophoresis. J. Biol. Chem. 247:566-571.
26. Maxwell, D. M., Lenz, D. E., Groff, W. A., Kaminskis, A., and Frochlich, H. L. 1987. The effects of blood flow and detoxification on in vivo chloinesterase inhibition by soman in rats. Toxicol. Appl. Pharmacol. 88:66-76.
27. May, D., Naukam, R., Kambam, R., and Branch, R. 1992. Cimetidine-carbaryl interaction in humans: Evidence for an active metabolite of carbaryl. J. Pharmacol. Exp. Ther. 262:1057-1061.
28. McCracken, N. W., Blain, P. G., and Williams, F. M. 1993. Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. Biochem. Pharmacol. 45:31-36.
29. McDougal, J. N., Jepson, G. W., Clewell, H. J. 3rd, Gargas, M. L., and Andersen, M. E. 1990. Dermal absorption of organic chemical vapors in rats and humans. Fundam. Appl. Toxicol. 14:299-308.
30. Mirfazaelian, A., Kim, K. B., Anand, S. S., Kim, H. J., Tornero-Velez, R., Bruckner, J. V., and Fisher, J. W. 2006. Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat. Toxicol. Sci. 93:432-442.
31. Mortensen, S. R., Hooper, M. J., and Padilla, S. 1998. Rat brain acetylcholinesterase activity: Developmental profile and maturational sensitivity to carbamate and organophosphorus inhibitors. Toxicology 125:13-19.
32. Mount, M. E., Dayton, A. D., and Oehme, F. W. 1981. Carbaryl residues in tissues and cholinesterase activities in brain and blood of rats receiving carbaryl. Toxicol. Appl. Pharmacol. 58:282-296.
33. Nostrandt, A. C., Duncan, J. A., and Padilla, S. 1993. A modified spectrophotometric method appropriate for measuring cholinesterase activity in tissue from carbaryl-treated animals. Fundam. Appl. Toxicol. 21:196-203.
34. Poet, T. S., Kousba, A. A., Dennison, S. L., and Timchalk, C. 2004. Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon. Neurotoxicology 25:1013-1030.
35. Poulin, P., and Krishnan, K. 1996. A mechanistic algorithm for predicting blood:air partition coefficients of organic chemicals with the consideration of reversible binding in hemoglobin. Toxicol. Appl. Pharmacol. 136:131-137.
36. Rao, P. S., Roberts, G. H., Pope, C. N., and Ferguson, P. W. 1994. Comparative inhibition of rodent and human erythrocyte acetylcholinesterase by carbofuran and carbaryl. Pestic. Biochem. Physiol. 48:79-84.
37. Renzi, B. E., and Krieger, R. I. 1986. Sublethal acute toxicity of carbosulfan [2,3-dihydro-2,2-dimethyl-7-benzofuranyl(di-n-butylaminosulfenyl)( methyl)carbamate] in the rat after intravenous and oral exposures. Fundam. Appl. Toxicol. 6:7-15.
38. Shealy, D. B., Barr, J. R., Ashley, D. L., Patterson, D. G., Camann, D. E., and Bond, A. E. 1997. Correlation of environmental carbaryl measurements with serum and urinary 1-naphthol measurements in a farmer applicator and his family. Environ. Health Perspect. 105:510-513.
39. Smith, B. J. 2005. Bayesian Output Analysis program (BOA), version 1.1.5. Ames: University of Iowa.
40. Sogorb, M. A., and Vilanova, E. 2002. Enzymes involved in the detoxification of organophosphorus, carbamate and pyrethroid insecticides through hydrolysis. Toxicol. Lett. 128:215-228.
41. 14C]carbaryl in pregnant, non-pregnant and fetal tissues of the rat after acute administration. Xenobiotica 10:113-124.
42. Suckow, M. A., Weisbroth, S. H., and Franklin, C. L., eds. 2005. The laboratory rat. Boston: Elsevier Academic.
43. Tanaka, R., Fujisawa, S., Nakai, K., and Minagawa, K. 1980. Distribution and biliary excretion of carbaryl, dieldrin and paraquat in rats: Effect of diets. J. Toxicol. Sci. 5:151-162.
44. Tang, J., Cao, Y., Rose, R. L., and Hodgson, E. 2002. In vitro metabolism of carbaryl by human cytochrome P450 and its inhibition by chlorpyrifos. Chem. Biol. Interact. 141:229-241.
45. Thrall, K. D., and Woodstock, A. D. 2002. Evaluation of the dermal absorption of aqueous toluene in F344 rats using real-time breath analysis and physiologically based pharmacokinetic modeling. J. Toxicol. Environ. Health A 65:2087-2100.
46. Timchalk, C., Nolan, R. J., Mendrala, A. L., Dittenber, D. A., Brzak, K. A., and Mattsson, J. L. 2002. A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. Toxicol. Sci. 66:34-53.
47. U.S. Environmental Protection Agency. 1999. Integrated Risk Information System (IRIS) on carbaryl. Washington, DC: National Center for Environmental Assessment, Office of Research and Development.
48. Wang, C., and Murphy, S. D. 1982. The role of non-critical binding proteins in the sensitivity of acetylcholinesterase from different species to diisopropyl fluorophosphate (DFP) in vitro. Life Sci. 31:139-149.
49. Ward, S., May, D., Heath, A., and Branch, R. 1988. Carbaryl metabolism is inhibited by cimetidine in the isolated perfused rat liver and in man. Clin. Toxicol. 26:269-281.
50. Whittaker, M. 1986. Cholinesterase. Monographs in Human Genetics, Vol. 11. Basel: Karger.